Holiday Inn Regents Park Hotel, London, UK (October, 19 - 20, 2015)
SMi Group is delighted to present their 4th annual Orphan Drugs and Rare Diseases Conference, taking place in London, UK, on 19th - 20th October 2015. Through a series of interactive presentations and panel discussions, event attendees will be able to learn how pharmaceutical, biotech, patient organisations and academia are structuring to participate and leverage the growing orphan market.Key topics include:
Benefits of Attending:
For further information go to: www.orphandrugs-event.com/gate2bio
Confirmed organisations include: GW Pharmaceuticals, PSR Orphan Experts, PSR Group B.V., Shire Pharmaceuticals Limited, Cello Health Insight - London, Infusion Pharma Consulting LLC, Otsuka Europe Development and Commercialisation
Event Speakers for 2015 include:
The event programme also includes two interactive half-day post-conference workshops:
Workshop leader: Colette Hamilton, Managing Director, ATP Market Access
Workshop leaders: Christa van Kan, Team Lead Clinical Execution, PSR Orphan Experts, Steve Phinder, PhD Director, Envestia Ltd, and Nicolas Sireau, PhD, Chairman and CEO, AKU Society
Sponsorship opportunities available. For more information please contact Alia Malick:
+44 (0) 7827 6168 or amalick@smi-online.co.uk
To register please contact Fateja Begum: +44 (0) 20 7827 6184 or mailto:fbegum@smi-online.co.uk
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology organizations - Biotech research institute, company, university, ..
Berkeley - University of California
A single dose of urea-powered nanorobots reduces bladder tumors by 90% in mouse study
Researchers develop a novel dry-powder inhaled vaccine platform